Of the three biomarkers, PARP1 was firstly validated as a novel diagnostic marker for HCC, GS is the classic marker for HCC [2, 15, 16], and NDRG1 is identified in HCC previously by our center [17] and other groups [18, 19]. The gene discussed is PARP1; the disease is hepatocellular carcinoma.